The H1 haplotype has been reported to be a primary factor for the associations of MAPT with Alzheimer’s disease (AD), progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and pathological tau aggregates in cognitively normal elderly [1–3]. Here, MAPT is linked to progressive supranuclear palsy.